The immune cell recruitment involves several inflammatory mediators, such as CCL2, S100A8/9, IL-1β, IL-5, GM-CSF and lipid-derived PGE2, which promote cancer-related inflammation, emergency myelopoiesis and tumor progression (Figure 2) [27,28,143]. This evidence concerns the gene IL1B and neoplasm.